SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061513
Filing Date
2023-11-09
Accepted
2023-11-09 07:05:09
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20231109.htm   iXBRL 8-K 47897
2 EX-99.1 rptx-ex99_1.htm EX-99.1 326260
3 GRAPHIC img233743075_0.jpg GRAPHIC 3037
  Complete submission text file 0000950170-23-061513.txt   513728

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20231109.xsd EX-101.SCH 2469
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20231109_lab.xml EX-101.LAB 13326
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20231109_pre.xml EX-101.PRE 9828
8 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20231109_htm.xml XML 4709
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 231390007
SIC: 2834 Pharmaceutical Preparations